STAT

JANUARY 24, 2024

You’ve heard of long Covid, a condition in which the acute infection subsides but troubling symptoms persist. Less well known is chronic Covid: The virus just doesn’t leave, sometimes staying in patients’ bodies long enough to mutate into new variants. This happens to people whose immune systems are compromised, whether through disease or treatment, leaving them vulnerable to infections that last weeks, months, or, in one known case, a year.

Immunity 362

Immunity Immunization 362

PharmaVoice

JANUARY 24, 2024

Executives on the healthcare giant’s full-year earnings call highlighted a strong cash position and incremental dealmaking as a way to get past incoming competition.

246

246

STAT

JANUARY 24, 2024

If you want an argument in favor of teaching the humanities, I suggest you ask a medical educator. Across the U.S., the age-old debate about the value of a liberal arts education has seemingly devolved into mortal combat, leaving the humanities in dire straits on college campuses. For example, the Atlantic recently reported on West Virginia University’s decision to gut its humanities programming, and the New York Times wondered whether the liberal arts will exist after the budget cuts hap

Medical Schools 361

Medical Schools 361

PharmaVoice

JANUARY 24, 2024

The most studied diseases last year included three types of cancer as research into COVID-19 fell sharply in the post-pandemic era.

163

163

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

JANUARY 24, 2024

In the spring of 2020, my almost 4-year-old daughter Livie sustained a severe traumatic brain injury (TBI) when a tree branch fell on her head in our backyard, devastating our whole family. Returning home after five months in the hospital, the real journey began : How do we best care for and support our daughter, who cannot do any daily activities on her own, cannot walk or talk, and has become cognitively impaired?

Hospitals 361

Hospitals 361

The Pharmacist

JANUARY 24, 2024

EXCLUSIVE: With the launch of Pharmacy First in England just days away, an under-pressure community pharmacy sector is torn between welcoming the opportunity and wondering whether patient demand will exceed its capacity. From 31 January, the launch of the highly anticipated service will see patients able to access advice and treatment for seven common conditions […] The post Pharmacy First: Are the floodgates about to open?

Community Pharmacies 135

Community Pharmacies 135

European Pharmaceutical Review

JANUARY 24, 2024

The first in our inaugural Pharma Horizons report series is dedicated to exploring the latest advances in artificial intelligence (AI) and machine learning (ML) for drug development, pharmaceutical manufacturing and quality control. AI/ML is predicted to be the top technology investment for 60 percent of life sciences companies over the next two years, according to a recent survey 1 from the Pistoia Alliance.

Pharmaceutical Manufacturing 127

Pharmaceutical Manufacturing Drug Development 127

STAT

JANUARY 24, 2024

A kind of protein implicated in Alzheimer’s disease might also contribute to the breakdown of cartilage that’s characteristic of osteoarthritis.  In a new study, published in Science Translational Medicine on Wednesday, researchers analyzed tissue samples and joint fluid from 12 people, both those with osteoarthritis and healthy controls.

315

315

BioPharma Dive

JANUARY 24, 2024

An 11-year-old boy born deaf can hear after receiving Lilly's genetic medicine. Others, including biotechs in China and Regeneron in the U.S., are taking aim at the same drug target.

115

115

STAT

JANUARY 24, 2024

The Dog Aging Project , which researchers say could yield promising leads for human longevity research, is at a critical crossroads after the National Institute on Aging declined to renew their grant funding. The massive project has been tracking the aging process of almost 50,000 companion dogs across the country through surveys and a biobank with over 14,000 tissue and other samples.

300

300

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

pharmaphorum

JANUARY 24, 2024

"The Omni Advantage: Accelerating the Behavioural Change with Omnichannel in Pharma Sales Engagement" is a game-changing book by businesswoman Merhnaz Campbell. Discover insights, strategies, and inspiration for pharma sales field team success.

112

112

STAT

JANUARY 24, 2024

The chemical used to sterilize half of all medical devices in the United States is also known to cause cancer. After years of deliberating on alternatives, the Food and Drug Administration this month deemed a safer gas , vaporized hydrogen peroxide, a legitimate way to decontaminate devices.  It’s a small step in pushing the medical device industry away from the carcinogenic chemical, called ethylene oxide.

290

290

pharmaphorum

JANUARY 24, 2024

CG Oncology completes the first biotech IPO of 2024, raising $380 million for its oncolytic virus bladder cancer immunotherapy.

131

131

STAT

JANUARY 24, 2024

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Hey there. So, today we talk about how Eli Lilly’s gene therapy, developed by Akuous, worked in a child born with an inherited form of deafness. Also, we see some interesting biopharma trends from Stifel, and consider Novo Nordisk’s new obesity investment that is tangential to GLP-1s.

Drug Pricing 258

Drug Pricing Drug Development 258

The Pharmacist

JANUARY 24, 2024

More than half a million women in England have accessed hormone replacement therapy (HRT) via the HRT pre-payment certificate (PPC) since its introduction last spring, the government has announced. The PPC scheme was launched on 1 April 2023, reducing prescription costs for eligible HRT items to £19.30 a year. Calculations from the Department of Health […] The post Over 500,000 women have accessed HRT through pre-paid certificates appeared first on The Pharmacist.

108

108

STAT

JANUARY 24, 2024

Good morning, everyone, and how are you today? We are doing just fine, thank you. Given that this is already the middle of the week and we have survived this far, no reason not to continue, yes? Just consider the alternatives. In fact, this modest accomplishment calls for celebration. So please join us in quaffing a ritual cup of needed stimulation.

Packaging 175

Packaging Vaccines 175

The Pharmacist

JANUARY 24, 2024

A new plan aiming to shore up the UK’s supply of pharmaceuticals has been unveiled by the government. As part of the Department for Business and Trade’s (DBT’s) recently launched Critical Imports and Supply Chains Strategy, an online portal will be set up to allow importers of essential goods – including medicines and healthcare supplies […] The post New government strategy targets medicine supply chain disruption appeared first on The Pharmacist.

104

104

Express Pharma

JANUARY 24, 2024

Venus Remedies has received Good Manufacturing Practices (GMP) certification for its facilities from the Ministry of Health, Libya. Saransh Chaudhary, CEO of Venus Medicine Research Centre, said, “The GMP certification from Libya adds to Venus Remedies’ portfolio of international approvals from 25 regulators, complementing our existing certifications in Africa from Morocco, South Africa, Tanzania, Kenya, Uganda, Sudan and other African countries.

104

104

Board Vitals - Pharmacist

JANUARY 24, 2024

The American Board of Internal Medicine (ABIM) offers initial certification exams across 19 medical specialties. Newly released pass rate data for 2023 sheds light on trends and challenges faced by healthcare professionals pursuing board certification. These statistics provide some extra insight on just how difficult the ABIM board exams are, and the importance of adequate exam prep.

101

101

PharmaTech

JANUARY 24, 2024

Under a new alliance, KBI Biopharma and Argonaut Manufacturing Services will combine their strengths to offer end-to-end biopharma development and CGMP manufacturing solutions.

98

98

Pharmacy Joe

JANUARY 24, 2024

In this episode, I’ll discuss how to guarantee you pick a great article for the journal club. Subscribe on iTunes , Android , or Stitcher There are two important criteria that are essential to fulfill when presenting an article to a journal club: 1. The article should be of high quality 2. The article should be relevant to clinical practice When an article meets these criteria, all parties at the journal club should benefit.

Inpatient 98

Inpatient Hospitals 98

pharmaphorum

JANUARY 24, 2024

Is the upcoming year set to be a year of major expansion, acquisitions, and deal-making in the business world? Stay informed about the potential trends and opportunities that await in the M&A landscape.

95

95

Outsourcing Pharma

JANUARY 24, 2024

Andrew Mills, executive vice president of global commercial Lokavant and says the company can help businesses identify risk trends in trials much earlier than traditional methods.

105

105

pharmaphorum

JANUARY 24, 2024

BenevolentAI’s search for a new chief executive has concluded with the appointment of industry bigwig Dr Jörg Möller to the role, four months after Joanna Shields stepped down and as the company emerges from a restructuring drive. The UK artificial intelligence specialist said in a statement that Möller is “an accomplished R&D leader and champion of the application of AI to drug discovery.

91

91

Pharmaceutical Technology

JANUARY 24, 2024

Accent Therapeutics has raised $75m in a Series C financing round to progress the development of precision cancer therapies.

109

109

pharmaphorum

JANUARY 24, 2024

LEO Pharma's chronic hand eczema drug delgocitinib has outperformed the only approved drug for the condition in a phase 3 trial.

106

106

Express Pharma

JANUARY 24, 2024

According to the EY report, 60 per cent of survey participants from the healthcare and life sciences sector believe Gen AI will have a significant impact on the entire value chain. The report, titled, ‘The AIdea of India: Generative AI’s potential to accelerate India’s digital transformation,’ highlights that while healthcare and life science sector has been traditionally conservative in adopting digital technologies, a gradual shift is underway.

Drug Development 87

Drug Development 87

Outsourcing Pharma

JANUARY 24, 2024

OM1 says it wants to stand at the helm of a healthcare revolution, fostering an integrated approach to generating and utilizing real-world evidence (RWE), reshaping the foundation of healthcare.

110

110

Express Pharma

JANUARY 24, 2024

Siemens Healthineers and the Indian Institute of Science (IISc) inaugurated the Siemens Healthineers-Computational Data Sciences (CDS) Collaborative Laboratory for AI in Precision Medicine at IISc Bangalore today. Peter Schardt, Chief Technology Officer of Siemens Healthineers, inaugurated this laboratory. The CDS collaborative laboratory will develop open-source AI-based tools to precisely automate the segmentation of pathological findings in neuroimaging data, with a focus on accurately diagno

85

85

Pharmaceutical Technology

JANUARY 24, 2024

The company could be in line for a priority review voucher if 4D-710, currently in Phase I/II clinical trials, is approved.

104

104

Outsourcing Pharma

JANUARY 24, 2024

Elisa Cascade is chief product officer at Advarra, a business that says it aims to advance the way clinical research is conducted by bringing life sciences companies, CROs, research sites, investigators, and academia together at the intersection of safety, technology, and collaboration.

105

105

pharmaphorum

JANUARY 24, 2024

BARDA has given $24 million to Locus Bio to support a mid-stage trial of bacteriophage therapy LBP-EC01 for resistant E coli infections.

98

98

Pharma Times

JANUARY 24, 2024

Patients living with sickle cell disease and thalassaemia will be eligible for the test

108

108

Outsourcing Pharma

JANUARY 24, 2024

Veevaâs Jim Reilly, vice president is Veeva Development Cloud strategy and along with countless others is getting excited about SCOPE 2024.

105

105

European Pharmaceutical Review

JANUARY 24, 2024

Topline data from a novel Phase III study show that the biologic TREMFYA ® (guselkumab) facilitated rapid and significant clearance in moderate to severe scalp psoriasis ( PsO ) and significant improvement in scalp itch at 16 weeks, according to Johnson & Johnson. It is the first prospective, large-scale, randomised-controlled clinical trial evaluating people of colour across all skin tones with moderate to severe plaque PsO and scalp PsO to objectively measure clearance and other treatment

78

78